Etomidate revisited.

Autor: Ostwald P; Institute of Anaesthesiology, Ludwig-Maximilians-University, Munich, Germany. ostwald@lrz.uni-muenchen.de, Doenicke AW
Jazyk: angličtina
Zdroj: Current opinion in anaesthesiology [Curr Opin Anaesthesiol] 1998 Aug; Vol. 11 (4), pp. 391-8.
DOI: 10.1097/00001503-199808000-00003
Abstrakt: The major advantage of etomidate is its lack of cardiovascular side effects. In addition, etomidate is supposed to be neuroprotective. The side effects of etomidate include adrenal suppression and myocloni. A review of the recent literature on etomidate, its clinical use, its side effects and its mechanism of action was performed. Among others, major recent advances include a new drug preparation devoid of propylene glycol and its side effects, a new pretreatment technique that may reduce the incidence of myocloni, and the identification of its site of action in the central nervous system.
Databáze: MEDLINE